ProQR Therapeutics
PRQR
PRQR
56 hedge funds and large institutions have $340M invested in ProQR Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 57 → 56 (-1)
7% less capital invested
Capital invested by funds: $364M → $340M (-$24.8M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $27K
Holders
56
Holding in Top 10
3
Calls
–
Puts
$27K
Top Buyers
| 1 | +$45.4M | |
| 2 | +$7.55M | |
| 3 | +$6.75M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$4.02M |
| 5 |
Goldman Sachs
New York
|
+$1.73M |
Top Sellers
| 1 | -$45M | |
| 2 | -$3.27M | |
| 3 | -$2.08M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.71M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
-$1.58M |